Home / Ayurcann CEO, Igal Sudman in conversation with Canadian Securities Exchange (CSE)
Phone: +1 905.492.3322Email: firstname.lastname@example.org
Phone: +1 844.226.2987Fax: +1.437.800.5140Email: email@example.com
Subscribe to our investor newsletter to stay updated with Ayurcann investor and public relations news.
Subscribe to our B2B newsletter to stay updated with Ayurcann services and partnership opportunities.